The invention relates to compounds and methods for inhibiting human
platelet aggregation, thrombosis and cell activation mediated by PAR1 and
PAR4 using peptide analogs of Arg-Pro-Pro-Gly-Phe that contain one or
more amino acid substitutions. The invention also includes screening
methods for identifying compounds that inhibit thrombin mediated
activities.